2008 International Symposium on Pharmaceuticals in the Home PMP/TDS Update Debra Brucker, M.P.A., Ph.D. Daniel Eccher, M.P.H. Maine Office of Substance.

Slides:

Advertisements

Similar presentations

June 20, 2005 Pharmaceutical Misuse & Abuse: from National to Local What the Data Say and Mean for Montgomery County Public Schools Presenter: Kenneth.

Advertisements

The Pharmaceutical Agent Order. Prescription An oral or written record of a physicians order to pharmacist to dispense medication to patient.

National Prescription Drug Threat Assessment 2009 National Drug Intelligence Center Drug Enforcement Administration.

Access To Recovery III GPRA Training Welcome Introductions Agenda

Standard 3 Plan and Manage Care NCQA Recognition for Patient-Centered Medical Home 2011 Standards © Qualidigm.

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015.

National Institute on Drug Abuse P rescription D rug A buse: An Escalating Public Health Threat P rescription D rug A buse: An Escalating Public Health.

Lock Your Meds BE AWARE. DON'T SHARE.. Your Home Medicine Cabinet: Does it look like this?

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

Controlled Substance Prescribing Trends and Physician and Pharmacy Utilization Patterns: Epidemiological Analysis of the Maine Prescription Monitoring.

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

VIRGINIA PRESCRIPTION MONITORING PROGRAM C.A.R.E Presentation February 27, 2015 Ralph Orr Director, Virginia Prescription Monitoring Program.

Maine’s Prescription Monitoring Program Maine Benzodiazepine Study Group Conference 2007 UPDATE Daniel J. Eccher, MPH Project Coordinator.

Using the Maine PMP to Improve Prescribing Practices for Potentially Addictive Prescription Medications Susan Payne, MPH, PhD Research Professor Institute.

NYS Resident Admissions to OASAS Certified Treatment Programs by Zip Code of Residence Jefferson County, Source: Office of Alcoholism and Substance.

Prescription Opioid Use and Opioid-Related Overdose Death — TN, 2009–2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence.

Lock Your Meds BE AWARE. DON'T SHARE. Sponsored by.

The South Florida Report January 2013 National Institute on Drug Abuse Community Epidemiology Work Group James N. Hall Report # 56 Center for Applied Research.

Pharmaceutical Drug Abuse Counterfeit Drugs. Current State of Affairs National drug prevalence studies indicate a sharp increase in prescription drug.

Prescription Drug Abuse/Misuse in Florida 2010 Florida Prevention Conference Orlando, Florida September 30, 2010 Hal Johnson, MPH Substance Abuse Program.

2015 User Conference Electronic Prescribing of Controlled Substances (EPCS) April 25, 2015 Presented by: Peter Minio Product Manager, Pediatric and Primary.

Prescription Drug Monitoring Program (PDMP) Maryland Alcohol and Drug Abuse Administration.

A New Generation of Prescription Monitoring Programs: Kentucky Is Adopting Best Practices University of Kentucky Lexington, KY Thursday, January 24, 2013.

California State Board of Pharmacy Continuing Education Program Senate Bill 151 (Burton)

The Prescription Behavior Surveillance System: Applications of De-identified PDMP Data in Public Health Surveillance Rx Abuse Summit April 23, 2014 Peter.

Dispensing to in and out patients or Drug distribution system

Wireless Password: NABP ® NEW TECHNOLOGY TO PREVENT DRUG DIVERSION AND DRUG ADMINISTRATION ERRORS NABP PERSPECTIVE Conference of Western Attorneys.

July 31, 2009Prepared by the Maine Health Information Center Overview of All Payer Claims Data Suanne Singer, Senior Consultant Maine Health Information.

1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;

Presenters Presenter name Date. Generation Rx – keep your family safe.

An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.

Department of Health and Vanderbilt University Chronic Pain Guidelines Symposium Elizabeth Lund, Executive Director, Board of Nursing Linda Johnson, APN.

Department of Health and Human Services Mental Health and Developmental Services Substance Abuse Prevention and Treatment Agency 11/14/20111.

Maine Prescription Monitoring Program Using the PMP to Improve Patient Care John Lipovsky, MPPM, AREM, PMM Prescription Monitoring Program Coordinator.

Welcome to Pharmacology MA 235 Instructor: Ryan Lambert- Bellacov.

Uniform Data System (UDS) Report 2005: Comparisons and Trends September 2006 Cassandra Arceneaux MD, MPH General Preventive Medicine Resident- UTMB.

Chapter 29 The PMP Not to be confused with 50 Cent’s song.

Buprenorphine Treatment for Opioid Dependence CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for.

The Impact of Integrated HIV Care on Patient Health Outcomes Tuyen Hoang, PhD Matthew B. Goetz, MD, Elizabeth Yano, PhD, Barbara Rossman, PhD, Henry D.

SOURCE: Treatment Episode Data Set (TEDS) 2005SOURCE: Treatment Episode Data Set (TEDS) 2005 Admissions to Substance Abuse Treatment for the Abuse of Opioid.

Maine’s Prescription Monitoring Program Daniel J. Eccher, MPH Project Coordinator Prescription Drug Misuse: A Community Challenge.

LECTURE FOR ASSIGNMENT 1 AND 2

John Lipovsky, MPPM, AREM, PMM

Pharmacology Fundamentals

State of Maine Prescription Monitoring Program (PMP) Maine's Prescription Monitoring Program (PMP) is a tool created to prevent and detect prescription.

DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration OFFICE OF APPLIED STUDIES Treatment Episode Data Set.

Prevention, Identification and Treatment of Opioid Use Disorders: A Personal Perspective Leah Bauer, MD Medical Director, Addiction Resource Center, Mid.

Drug schedules CSA created 5 ‘controlled drug’ schedules. non controlled drugs can have unlimited refills for a year after rx date. schedule I------no.

Maine Prescription Monitoring Program Using the PMP to Improve Patient Care John Lipovsky, MPPM, AREM, PMM Prescription Monitoring Program Coordinator.

Table of Contents.  Legal and Safety Issues Go Go  Prescriptions and Abbreviations Go Go.

Inside Maine’s Medicine Cabinet. Inside Maine’s Medicine Cabinet: Analysis of the Maine Prescription Monitoring Program, Christina Holt, MD,

MmPHR Use Cases Oxyconton Fraud Business Model Rubina Lakhani March 2, 2016.

Maine Prescription Monitoring Program Using the PMP to Improve Patient Care John Lipovsky, MPPM, AREM, PMM Prescription Monitoring Program Coordinator.

Maine Prescription Monitoring Program Using the PMP to Improve Patient Care John Lipovsky, MPPM, AREM, PMM Prescription Monitoring Program Coordinator.

Erin Herzig Valley Medical Group Opioid Education and Awareness Task Force.

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Pennsylvania's Prescription Drug Monitoring Program (PDMP) May 17, 2016.

Inventory Management Chapter 13.

Drug Formulary Commission

American Public Health Association Annual Meeting November 5, 2007

The Foggy Future of Form 5500 Filings Bad News, Made Just a Bit Better With the Help of A Few Cute Cats. By Benjamin Davis.

Drug schedules CSA created 5 ‘controlled drug’ schedules. non controlled drugs can have unlimited refills for a year after rx date. schedule I------no.

An Overview of the ePDMP

CPRS Version 29: New Functionalities

Department of Health Management and Informatics

Controlled Substance Monitoring & Legislative updates

Training for provider relations representatives and PMP offices

Barbara Allison-Bryan, MD

Only 28% of U.S. Primary Care Physicians Have Electronic Medical Records; Only 19% Advanced IT Capacity, 2006 Percent reporting 7 or more out of 14 functions*

Illinois Prescription Monitoring Program

PMP Advisory Committee

Presentation transcript:

2008 International Symposium on Pharmaceuticals in the Home PMP/TDS Update Debra Brucker, M.P.A., Ph.D. Daniel Eccher, M.P.H. Maine Office of Substance Abuse

PMP Overview Data collection began July 1, 2004 Data submitted by over 300 pharmacies in and out of state DEA Schedules II, III, and IV Patient-specific data directly accessible to a select few people (e.g., physicians) Intent: health care tool for reducing accessibility of controlled substances for non-medical use

PMP Limitations Accuracy and completeness of data up to pharmacies Many new data submitters came online in 2008 No unique identifiers; no legal ID requirement Prescriptions written for various time periods and quantities – best way to analyze unknown

Overall CS Counts SFY08

Tranquilizer Rx Counts SFY08

Lorazepam by Age Group Maine Patients, SFY 2008

Clonazepam Maine Patients, SFY 2008

Alprazolam Maine Patients, SFY 2008

Diazepam Maine Patients, SFY 2008

Benzodiazepine Rx Counts: Trends Maine Patients,

All Benzodiazepines, Maine Pts.

“Top 5” Benzos by Rx Count (Maine Patients, )

Treatment Data System (TDS) Data submitted to OSA by substance abuse treatment providers throughout Maine Government-funded programs required Some privately funded programs voluntarily submit Monthly checks on accuracy and completeness of data Comprehensive picture of SA treatment in Maine

Admissions to Treatment: Primary Drug = Benzodiazepine

Admissions to Treatment: Secondary Drug = Benzodiazepine

Admissions to Treatment: Tertiary Drug = Benzodiazepine

Treatment Admissions by Primary Drug,

Questions? (207)